Form D · Other Technology
Natrx, Inc.
Raleigh, NC · CIK 0001975848
Offering snapshot reported May 8, 2023 · SEC filing
- Reported sold
- $709K Offering amount: $709K
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 16, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 8, 2023 | Initial | $709,000 | No comparison | 10 | SEC filing |
| May 5, 2023 | Initial | $948,000 | No comparison | 26 | SEC filing |
| May 4, 2023 | Initial | $1,500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-481028
SAFE Notes
Source: Form D, filed May 8, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Campbell | Director, Executive |
| Leonard Nelson | Director, Executive |
| Evi Steyer | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
6220 Angus Dr Suite 101
Raleigh, NC, 27617
Raleigh, NC, 27617